{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:29:45Z","timestamp":1759742985421},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077375","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T16:27:16Z","timestamp":1381508836000},"page":"e77375","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeting c-MYC with T-Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Florian","family":"Helm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kammertoens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank M.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg W.","family":"Bornkamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Gerbitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrc3246","article-title":"The determinants of tumour immunogenicity","volume":"12","author":"T Blankenstein","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"CV Dang","year":"2012","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0993-56","article-title":"Point mutations in the c-Myc transactivation domain are common in Burkitt&apos;s lymphoma and mouse plasmacytomas","volume":"5","author":"K Bhatia","year":"1993","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood.V84.3.883.883","article-title":"Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas","volume":"84","author":"K Bhatia","year":"1994","journal-title":"Blood"},{"key":"ref5","first-page":"759","article-title":"Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt&apos;s lymphoma cell lines","volume":"9","author":"T Albert","year":"1994","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0092-8674(83)90449-X","article-title":"Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men","volume":"32","author":"G Klein","year":"1983","journal-title":"Cell"},{"key":"ref7","first-page":"803","article-title":"Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays","volume":"59","author":"L Bubendorf","year":"1999","journal-title":"Cancer Res"},{"key":"ref8","first-page":"1966","article-title":"Tissue microarrays for gene amplification surveys in many different tumor types","volume":"5","author":"P Schraml","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"TC He","year":"1998","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature05674","article-title":"Myc deletion rescues Apc deficiency in the small intestine","volume":"446","author":"OJ Sansom","year":"2007","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"L Soucek","year":"2008","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","article-title":"Reversible tumorigenesis by MYC in hematopoietic lineages","volume":"4","author":"DW Felsher","year":"1999","journal-title":"Mol Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1071489","article-title":"Sustained loss of a neoplastic phenotype by brief inactivation of MYC","volume":"297","author":"M Jain","year":"2002","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nature03043","article-title":"MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer","volume":"431","author":"CM Shachaf","year":"2004","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","article-title":"Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression","volume":"109","author":"S Pelengaris","year":"2002","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1947601910377494","article-title":"Therapeutic Targeting of Myc","volume":"1","author":"EV Prochownik","year":"2010","journal-title":"Genes Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.18632\/oncotarget.396","article-title":"Finding cancer&apos;s weakest link","volume":"2","author":"NM Sodir","year":"2011","journal-title":"Oncotarget"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1363","article-title":"Autoimmunity and tumor immunity induced by immune responses to mutations in self","volume":"12","author":"ME Engelhorn","year":"2006","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.4049\/jimmunol.170.10.5188","article-title":"A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen","volume":"170","author":"JS Gold","year":"2003","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse","volume":"192","author":"AL Kovalchuk","year":"2000","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00251-010-0493-5","article-title":"HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides","volume":"63","author":"M Erup Larsen","year":"2011","journal-title":"Immunogenetics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"M Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/eji.200939613","article-title":"In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes","volume":"40","author":"YY Setiady","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature03954","article-title":"Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance","volume":"437","author":"G Willimsky","year":"2005","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e34552","DOI":"10.1371\/journal.pone.0034552","article-title":"Stromal Interferon-gamma Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice","volume":"7","author":"A Gerbitz","year":"2012","journal-title":"PLOS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00109-002-0360-4","article-title":"Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cells","volume":"80","author":"T Sch\u00fcler","year":"2002","journal-title":"J Mol Med (Berl)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions","volume":"21","author":"L Ohl","year":"2004","journal-title":"Immunity"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.189.2.371","article-title":"Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization","volume":"189","author":"A Regnault","year":"1999","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4049\/jimmunol.144.4.1531","article-title":"Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes","volume":"144","author":"RJ Barth Jr.","year":"1990","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6","article-title":"Cell cycle activation by c-myc in a burkitt lymphoma model cell line","volume":"87","author":"A Pajic","year":"2000","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ccr.2011.10.019","article-title":"Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer","volume":"20","author":"K Anders","year":"2011","journal-title":"Cancer Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"SA Rosenberg","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"NP Restifo","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bcmd.2004.08.018","article-title":"WT1-targeted immunotherapy of leukaemia","volume":"33","author":"S Xue","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1182\/blood-2009-03-209387","article-title":"Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity","volume":"114","author":"S Wilde","year":"2009","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm.2197","article-title":"Transgenic mice with a diverse human T cell antigen receptor repertoire","volume":"16","author":"LP Li","year":"2010","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1200\/JCO.2006.07.1100","article-title":"Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma","volume":"24","author":"A Mackensen","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jnci\/88.2.100","article-title":"Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy","volume":"88","author":"NP Restifo","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo","volume":"192","author":"C Yee","year":"2000","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nm999","article-title":"Bystander elimination of antigen loss variants in established tumors","volume":"10","author":"MT Spiotto","year":"2004","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00262-011-1076-5","article-title":"Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity","volume":"60","author":"X Yan","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"A Corthay","year":"2005","journal-title":"Immunity"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.4049\/jimmunol.179.10.6651","article-title":"CD8 T cell help for innate antitumor immunity","volume":"179","author":"A Shanker","year":"2007","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.002","article-title":"CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation","volume":"18","author":"K Rakhra","year":"2010","journal-title":"Cancer Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0065-230X(08)60353-X","article-title":"Proteins of the Myc network: essential regulators of cell growth and differentiation","volume":"68","author":"M Henriksson","year":"1996","journal-title":"Adv Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e42021","DOI":"10.1371\/journal.pone.0042021","article-title":"Humanized c-Myc Mouse","volume":"7","author":"FM Lehmann","year":"2012","journal-title":"PLOS ONE"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1172\/JCI43437","article-title":"MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors","volume":"120","author":"M Leisegang","year":"2010","journal-title":"J Clin Invest"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"R Wang","year":"2011","journal-title":"Immunity"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.185.12.2043","article-title":"HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice","volume":"185","author":"S Pascolo","year":"1997","journal-title":"J Exp Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1101\/gad.14.11.1390","article-title":"N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation","volume":"14","author":"BA Malynn","year":"2000","journal-title":"Genes Dev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T07:36:10Z","timestamp":1688542570000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077375"}},"subtitle":[],"editor":[{"given":"Andrei\u00a0L.","family":"Gartel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077375","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}